logo
[breadcrumb_custom]

Tag: Summit Therapeutics Inc. (NASDAQ:SMMT)
Stock

Summit Therapeutics Inc Inc. (SMMT) Price Performance: The Role of Supply and Demand

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price gain of 53.26% this year. Over the last six months, there has been a weaker performance of 139.52%. The price of SMMT leaped by -6.98% during the last 30 days period. For the last 5-days stocks have improved 1.27%. Summit Therapeutics Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $5.22 on 03/05/24, and the lowest price during the same period
Finance

SMMT’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price gain of 35.63% this year. Over the last six months, there has been a weaker performance of 100.00%. The price of SMMT leaped by -30.18% during the last 30 days period. For the last 5-days stocks have slided -5.60%. Summit Therapeutics Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $5.22 on 03/05/24 and the lowest value was $1.30
Finance

Summit Therapeutics Inc (SMMT) Stock: Navigating a Year of Stock Volatility

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Summit Therapeutics Inc’s current trading price is -28.35% away from its 52-week high, while its distance from the 52-week low is 187.69%. The stock’s price range over this period has fluctuated between $1.30 and $5.22. The company, operating within the financial sector, had a trading volume of approximately 2.98 million for the day, which was noticeably higher than the average daily share volume of 2.25 million over the last 3 months. Summit Therapeutics Inc experienced a rather

DOYU
Industry

Summit Therapeutics Inc (SMMT) Stock: A Year of Declines and Increases

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Summit Therapeutics Inc’s current trading price is -21.17% away from its 52-week high, while its distance from the 52-week low is 216.54%. The stock’s price range for this time frame has been between $1.30 and $5.22. The trading volume of the company’s shares in the Healthcare reached around 2.28 million for the day, which was evidently higher than the average daily volume of 2.13 million over the last three months. The stock market performance of Summit Therapeutics Inc has

TOST Stock
Stock

SMMT’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect?

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 72.80%. However, over the past six months, we’ve seen a weaker performance of 151.96%. The price of SMMT leaped by -3.43% over the last 30 days. And in the last five days, it has fallen by -6.82%. The stock market performance of Summit Therapeutics Inc has been very steady. Over the last year, the company’s stock hit its highest at $5.22 on 03/05/24, while the
Industry

Summit Therapeutics Inc (SMMT) Stock: A Year of Market Fluctuations

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Summit Therapeutics Inc’s current trading price is -1.36% away from its 52-week high, while its distance from the 52-week low is 305.60%. The stock’s price range over this period has fluctuated between $1.25 and $5.14. The company, operating within the financial sector, had a trading volume of approximately 2.66 million for the day, which was noticeably higher than the average daily share volume of 1.91 million over the last 3 months. Summit Therapeutics Inc’s market performance has

Investchronicle.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.
Facebook-f Twitter Google-plus-g Pinterest

Quick Links

Categories

©Fueled By Smart TechOne